Crystal structure of actinomycin D bound to the CTG triplet repeat sequences linked to neurological diseases
The potent anticancer drug actinomycin D (ActD) acts by binding to DNA GpC sequences, thereby interfering with essential biological processes including replication, transcription and topoisomerase. Certain neurological diseases are correlated with expansion of (CTG)(n) trinucleotide sequences, which...
I tiakina i:
| I whakaputaina i: | Nucleic Acids Res |
|---|---|
| Ngā kaituhi matua: | , , , |
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Oxford University Press
2002
|
| Ngā marau: | |
| Urunga tuihono: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC137167/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12433994/ https://ncbi.nlm.nih.govhttps://doi.org/10.1093/nar/gkf619 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
